Optimizing Noisy Galvanic Vestibular Stimulation Frequency Range for Enhancing Vestibular Perception and Manual Control Performance

NCT07730398 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2026-07-28

No results posted yet for this study

Summary

This randomized crossover interventional study evaluated the effects of different frequency ranges of noisy galvanic vestibular stimulation (nGVS) on vestibular perception, perceptual motion tracking, and manual control performance in healthy adults. Each participant completed three experimental conditions in randomized order: no stimulation (control), low-frequency nGVS, and high-frequency nGVS. Vestibular perceptual thresholds, perceptual tracking, and manual control performance were assessed during each condition to determine whether stimulation frequency influenced sensorimotor function.

Conditions

  • Vestibular Function Tests
  • Sensorimotor Performance

Interventions

DEVICE

Low-frequency noisy galvanic vestibular stimulation (nGVS)

Participants received low-frequency noisy galvanic vestibular stimulation through electrodes placed over the bilateral mastoid processes during experimental testing. Stimulation parameters were consistent with the approved study protocol. Frequency was 0-2Hz white noise, 300uA amplitude.

DEVICE

High-frequency noisy galvanic vestibular stimulation (nGVS)

Participants received high-frequency noisy galvanic vestibular stimulation through electrodes placed over the bilateral mastoid processes during experimental testing. Stimulation parameters were consistent with the approved study protocol. Frequency was 10-30Hz white noise, 300uA amplitude.

Sponsors & Collaborators

  • National Aeronautics and Space Administration (NASA)

    lead FED

Principal Investigators

  • Scott J Wood, PhD · National Aeronautics and Space Administration (NASA)

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-19
Primary Completion
2024-03-18
Completion
2024-03-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07730398 on ClinicalTrials.gov